No items found

Treatment Success Seen With Antibiotics for Uncomplicated Appendicitis

Share on facebook
Share on twitter
Share on linkedin
Share on email

Key Takeaways

  • Treatment success rates ≥65% for uncomplicated appendicitis are seen with both oral antibiotics and combined intravenous and oral antibiotics.
  • The researchers found that the treatment success rate at one year was 70.2% and 73.8% for patients treated with oral antibiotics and intravenous followed by oral antibiotics, respectively.
  • Patients with uncomplicated appendicitis should be offered a treatment choice between surgery and antibiotics alone.

HealthDay News — For adults with uncomplicated acute appendicitis, treatment success rates ≥65% are seen with both oral antibiotics and combined intravenous and oral antibiotics, according to a study published in the Journal of the American Medical Association.

Suvi Sippola, M.D., from Turku University Hospital in Finland, and colleagues compared oral antibiotics to combined intravenous followed by oral antibiotics in 599 patients aged 18 to 60 years with computed tomography-confirmed uncomplicated acute appendicitis. Participants were randomly assigned to either oral moxifloxacin for 7 days or intravenous ertapenem for 2 days followed by oral levofloxacin and metronidazole for 5 days. Overall, 581 patients were available for 1-year follow-up. The primary end point was treatment success (≥65%); a margin of 6% for the difference between the treatment groups was used to determine noninferiority of oral antibiotics alone.

The researchers found that the treatment success rate at one year was 70.2% and 73.8% for patients treated with oral antibiotics and intravenous followed by oral antibiotics, respectively. The difference was −3.6% (P =.26 for noninferiority), with the confidence limit exceeding the margin for noninferiority.

“The current evidence supports that patients with uncomplicated appendicitis should be offered a treatment choice between surgery and antibiotics alone,” write the authors of an accompanying editorial. “The key to moving forward is getting that evidence into practice.”

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text

Editorial

Leave a Reply

Your email address will not be published. Required fields are marked *

Want to continue reading this article?

Log in to your account